raw materials – Page 18

Segregation controls inadequate during regulatory inspection – inspection defense documentation

Insufficient Segregation Controls During Regulatory Inspections: A Comprehensive Playbook for Pharma Professionals In the high-stakes environment of pharmaceutical manufacturing, maintaining stringent segregation controls is essential to comply with regulatory standards…

Sampling plan not risk-based during deviation investigation – root cause analysis for sampling failures

Root Cause Analysis for Non Risk-Based Sampling Plans During Deviation Investigations In pharmaceutical manufacturing, a well-structured sampling plan is crucial for ensuring material quality and compliance. However, deviations can occur…

Material mix-up incident reported during regulatory inspection – traceability system expectations

Addressing a Reported Material Mix-Up Incident During Regulatory Inspections: A Comprehensive Playbook Material mix-up incidents can lead to significant regulatory scrutiny, especially during inspections by authorities such as the FDA,…

Sampling SOP not followed during incoming material receipt – preventing false OOS results

Mitigating Risks from Improper Sampling SOP During Incoming Material Receipt In the pharmaceutical industry, adherence to Standard Operating Procedures (SOPs) regarding the sampling of incoming materials is critical to ensuring…

Barcode system failure during warehouse operations – preventing repeat mix-up events

Preventing Repeat Mix-Up Events Due to Barcode System Failures in Warehouse Operations Barcode systems are industry standards for ensuring material traceability during warehouse operations. Yet, when these systems fail, the…

Cross-contamination during sampling during internal audit – root cause analysis for sampling failures

Investigating Cross-contamination During Internal Audit Sampling Failures Cross-contamination during sampling can have significant implications for product quality, regulatory compliance, and overall pharmaceutical safety. This article guides pharmaceutical professionals through the…

Barcode system failure during regulatory inspection – CAPA and system strengthening

Addressing Barcode System Failures During Regulatory Inspections: A Practical Playbook Barcode systems are fundamental to maintaining material traceability and ensuring compliance during regulatory inspections. However, what happens when these systems…

Cross-contamination during sampling during incoming material receipt – GMP expectations for material sampling

Investigating Cross-Contamination Risks During Incoming Material Sampling Cross-contamination during sampling at the incoming material stage poses a significant risk not only to product quality but also to regulatory compliance. This…

Material mix-up incident reported during dispensing – preventing repeat mix-up events

Preventing Repeat Material Mix-Up Incidents During Dispensing Material mix-up incidents during dispensing can drastically impact product quality and regulatory compliance. Such events may lead not only to significant financial losses…

Sampling plan not risk-based during deviation investigation – CAPA to prevent recurrence

Deviations Due to Non-Risk-Based Sampling Plans: Investigating the Root Causes and CAPAs Deviations in pharmaceutical manufacturing often arise from inadequate sampling plans that fail to consider risk factors, leading to…

Labeling mismatch detected during investigation – preventing repeat mix-up events

Addressing Labeling Mismatches During Investigations to Avoid Future Mix-Up Issues Labeling mismatches in pharmaceutical manufacturing can lead to significant quality control issues, regulatory scrutiny, and potential product recalls. This article…

Sampler training deficiency during incoming material receipt – CAPA to prevent recurrence

Addressing Deficiencies in Sampler Training During Incoming Material Receipt Deficiencies in sampler training during the receipt of incoming materials can lead to significant quality risks in pharmaceutical manufacturing. These risks…